Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

July 18, 2000

3 Brands of Aspirin Tablets Recalled by Leiner Health Products

Carson, CA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Leiner Health Products is conducting a recall of certain aspirin tablets because of dissolution failure (24 month stability).

Aspirin Tablets, 325 mg, in units of 2, 100, and 300, Rx under the Pharmacist Formula (2 tablets), Albertson (100 count), and Target (300 count) labels

Recall #D-432-0.  Class III

Lot #8M00476 EXP 10/01.

Leiner Health Products, Inc., Kalamazoo, Michigan.

Leiner Health Products, Inc., Carson, California, by letter faxed on May 2, 2000, followed by mail on May 3, 2000. Firm-initiated recall ongoing.  This is the first public notice issued by the FDA.

California, Florida, Idaho, Hawaii, Illinois, Maryland, Minnesota, Texas, Virginia.

47,832 10-tablet bottles; 9,276 300-count bottles and 5,424 boxes 100 tablet blisters were distributed.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafeMail subscribers July 18, 2000.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.